Actavis Fentanyl Pain Patch

Tweet

The Actavis Fentanyl Transdermal System is manufactured by Actavis South Atlantic LLC , formerly known as Abrika Pharmaceuticals Inc. The FDA has received hundreds of reports of fatalities linked to the use of fentanyl transdermal pain patches. The cause of these deaths can be due to seal breaches allowing fentanyl gel to leak from the patch, known as the “fold-over defect,” malfunction of the rate control membrane, or other defects.

Free Fentanyl Pain Patch Case Evaluation: If you or a loved one has been injured by any type of fentanyl pain patch, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

On February 17, 2008, the pharmaceutical company Actavis, formerly known as Abrika Pharmaceuticals, announced a recall of 14 lots of their generic fentanyl transdermal system. They ranged from 25 to 100 mcg/hr doses and had expiration dates between May and August 2009. The product bore both the Actavis logo and an Abrika Pharmaceuticals label.

Two weeks later, on March 3, 2008, Actavis extended the action to every remaining Actavis fentanyl patch being sold in the United States. The company noted that this was a “precautionary measure,” as they lacked assurance that all were free from defects.

Actavis directed consumers to flush any damaged products that they discovered. They should also wash any skin exposed directly to the gel with water, but not soap. Anyone who experiences the symptoms of a fentanyl overdose after using one of these should immediately contact a medical professional.

Do I have a Fentanyl Pain Patch Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in fentanyl patch lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.